Mayne-Sun US Settlement Keeps Generic Imvexxy Out Til 2032
ASX-listed Mayne Pharma announced a settlement in a US patent dispute with Sun Pharmaceuticals Industries Ltd. on Wednesday over an oestradiol vaginal insert used to treat symptoms of menopause, with Sun...To view the full article, register now.
Already a subscriber? Click here to view full article